PDL

Alexion Pharmaceuticals and PDL BioPharma Resolve Patent Dispute

Alexion Licenses PDL's Queen et al. Patents for Soliris(R) INCLINE VILLAGE, Nev., and CHESHIRE, Conn., Jan. 5 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc. (Nasdaq: PDLI ) and Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN ) today jointly announced that the companies have entered into a d...

PDL BioPharma Elects Barry Selick to Its Board of Directors

...NE VILLAGE, Nev., Aug. 3 /PRNewswire-FirstCall/ -- pdl BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today anno...ersity of California, San Francisco. About pdl BioPharma, Inc. pdl BioPharma pioneered the humanization of monoclonal...

PDL BioPharma Announces Second Quarter 2009 Financial Results

...E VILLAGE, Nev., July 30 /PRNewswire-FirstCall/ -- pdl BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today repo...Laughlin, president and chief executive officer of pdl BioPharma. "We paid our first post spin-off divide...lion for the first half of 2008. At June 30, 2009, pdl had cash, cash equivalents, short-term investments...

PDL BioPharma to Announce Second Quarter 2009 Financial Results and Hold Conference Call July 30, 2009

...E VILLAGE, Nev., July 22 /PRNewswire-FirstCall/ -- pdl BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today anno...re download that may be necessary. About pdl BioPharma, Inc. pdl BioPharma pioneered the humanization of monoclonal...

New Report Just Published: World Multiple Myeloma Therapeutics Market Report

... CytRx to Acquire Innovive II-45 Launch of Epoetin alfa Hexal II-45 pdl and Bristol-Myers Signs Agreement II-45 MNKD and LLS Conclude Joint Res...I-47 Bristol-Myers to Take Over Kosan Biosciences II-47 Bristol and pdl BioPharma Enter into Agreement II-47 Gamida Cell Enters Into a Agreemen...

Studies Highlight A Revolutionary New Method of Treating Post-Operative Bruising

... second study, a 2009 ASLMS abstract , entitled: " A Simple Solution to a Common Problem" evaluated the effectiveness and safety of the long-pulse pdl (the Vbeam ) for the treatment of ecchymoses. In this study by Elizabeth Hale, M.D., Julie Karen, M.D., Chris Hunzeker, M.D., Elliot Weiss, M.D....

PDL BioPharma Announces Record Date for October 1 Dividend Payment

...E VILLAGE, Nev., June 10 /PRNewswire-FirstCall/ -- pdl BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today announced that all shareholders owning shares of pdl on September 17, 2009, will be paid a dividend of ...il 1, 2009 to all stockholders who owned shares of pdl on March 16, 2009. About...

Studies Highlight a Revolutionary New Method of Treating Post-Operative Bruising

...ond study, a 2009 ASLMS abstract, entitled: "A Simple Solution to a Common Problem" evaluated the effectiveness and safety of the long-pulse pdl (the Vbeam) for the treatment of ecchymoses. In this study by Elizabeth Hale, M.D., Julie Karen, M.D., Chris Hunzeker, M.D., Elliot Weiss, M.D., Leon...

PDL BioPharma Appoints Karen J. Wilson as Vice President, Finance and Principal Accounting Officer

... VILLAGE, Nev., April 29 /PRNewswire-FirstCall/ -- pdl BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today anno...enty years of finance and accounting experience to pdl with specific expertise with life science companie...Laughlin, president and chief executive officer of pdl BioPharma. Most recently, from 2005 to 2009, ...

Milestone Scientific Hosts Second Annual Symposium on Computer-Controlled Local Anesthetic Delivery (C-CLAD)

...dy STA Compassionate Care in the 21st Century Injection Advances and Challenges Physiologic and Clinical Characteristics of pdl Anesthesia Delivered by a High Pressure Syringe and a Computerized Device The STA for Tots and Teens Computerized Local Anesthesia i...

PDL in Medical Technology

Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients With Relapsing Multiple Sclerosis

...07 /PRNewswire-FirstCall/ -- Biogen Idec, Inc. and pdl BioPharma, Inc. (PDL) announced today that the ong...in patients with relapsing MS." "We congratulate pdl on conducting a successful trial of daclizumab in ...cebo added to ongoing interferon beta treatment. pdl and Biogen Idec entered into a collaboration agree...

PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week

...32). The data from this study are intriguing, and pdl is assessing options for further study in this patient population. About pdl BioPharma pdl BioPharma, Inc. is a biopharmaceutical company foc...

PDL in Biological Technology

Genmab and PDL BioPharma Close Sale of Antibody Manufacturing Facility

Summary: Genmab's Acquisition of PDL BioPharma's Antibody Manufacturing Facility has Closed. COPENHAGEN, Denmark and REDWOOD CITY, California, March 14 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) and PDL BioPharma, Inc. (Nasdaq: PDLI ) today announced the closing ...

Otsuka Pharmaceutical and PDL BioPharma Close Sale of IV Busulfex

PRINCETON, N.J., TOKYO, and REDWOOD CITY, Calif., March 10 /PRNewswire-FirstCall/ -- Otsuka Pharmaceutical Co., Ltd. (OPC) and PDL BioPharma, Inc. (Nasdaq: PDLI ) today announced the closing of the previously announced transaction under which Otsuka has acquired PDL's rights to IV Busulfex(R)...

Genmab and PDL BioPharma Sign Purchase Agreement for Antibody Manufacturing Facility

Summary: Genmab and PDL BioPharma Have Entered into an Agreement Under Which Genmab Will Acquire PDL's Antibody Manufacturing Facility Located in Brooklyn Park, Minnesota, USA COPENHAGEN, Denmark and REDWOOD CITY, California, February 21 /PRNewswire-FirstCall/ -- Genmab A...

PDL BioPharma to Present at BMO Capital Markets Healthcare Conference on August 5, 2009

...E VILLAGE, Nev., July 29 /PRNewswire-FirstCall/ -- pdl BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today anno...urs after completion of the webcast. About pdl BioPharma, Inc. pdl BioPharma pioneered the humanization of monoclonal...

PDL BioPharma Provides Second Quarter 2009 Revenue Guidance of Approximately $125 Million

...NE VILLAGE, Nev., June 8 /PRNewswire-FirstCall/ -- pdl BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today anno...l published results may differ from such guidance. pdl plans to release its financial results for the sec...e call will be announced in late July. About pdl BioPharma, Inc. ...

PDL BioPharma Announces First Quarter 2009 Financial Results

...INE VILLAGE, Nev., May 7 /PRNewswire-FirstCall/ -- pdl BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today repo...end in April, a result of the revenues and profits pdl is generating from royalties on a diversified port...Laughlin, president and chief executive officer of pdl BioPharma. "Our new and focused strategy seeks to ...

AMDL, Inc. Signs First Customer Agreement With Precision Diagnostic Laboratory for DR-70 (FDP) Cancer Test

... pdl first diagnostic laboratory to offer DR-70 diagnos...ncer test to patients and doctors in the US. pdl Inc. is a full-service, CAP (College of American P... accurate diagnostic testing. With this agreement, pdl is the first diagnostic laboratory in the US to of...

Pilot Study Finds Adding Topical Imiquimod To Laser Therapy Improves The Response Of Port Wine Stain Birthmarks

...irthmarks who were treated with either regimens of pdl plus Imiquimod; pdl alone; or Imiquimod alone. Recently published in ... port wine stain blood vessel recurrence following pdl therapy. The present study represents an off-labe...

Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing

...ied physician in internal medicine and rheumatology. Having worked in industry for 15 years, she has successfully led product development programs for pdl BioPharma, Immunex Corporation (acquired by Amgen), where she led the Enbrel(R) development team for rheumatoid arthritis in adults and children throu...

ARIUS announces second quarter fiscal 2008 financial results

...arch contract revenue from the Takeda collaboration and the recognition of licensing fee revenue for an extension fee payment under the agreement with pdl Biopharma Inc. For the six-month period ended May 31, 2008, the Company's interest income decreased to $176,512 compared to $381,407 for the same pe...